SCHEMBL19744072

SCHEMBL19744072

O=C(NCc1ccccc1)c1cc(=O)c2ccccc2o1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 1.00
POLB P06746 4/20 0.76
KDM4E B2RXH2 1/20 0.69
USP2 O75604 1/20 0.69
CSNK2A2 P19784 1/20 0.69
PTGS1 P23219 1/20 0.69
CSNK2B P67870 1/20 0.69
CSNK2A1 P68400 1/20 0.69
CSNK2A3 Q8NEV1 1/20 0.69
ALDH1A1 P00352 1/20 0.69
TP53 P04637 1/20 0.69
HPGD P15428 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
HTT P42858 1/20 0.67
METTL3 Q86U44 3/20 0.64
METTL14 Q9HCE5 1/20 0.64
KMT2A Q03164 2/20 0.64
THRB P10828 1/20 0.64
MEN1 O00255 1/20 0.63
ATM Q13315 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21174969 0.89 LMNA (0.80) LMNAPOLBKDM4EUSP2CSNK2A2
SCHEMBL27582528 0.87 LMNA (0.77) LMNAPOLBKDM4EUSP2CSNK2A2
SCHEMBL19745162 0.86 LMNA (0.74) LMNAPOLBALDH1A1TP53HPGD
SCHEMBL5206502 0.84 LMNA (0.72) LMNAPOLBKDM4EUSP2CSNK2A2
SCHEMBL23662351 0.84 LMNA (0.72) LMNAPOLBALDH1A1TP53HPGD
SCHEMBL19743978 0.83 LMNA (0.71) LMNAPOLBKDM4EUSP2CSNK2A2
Chromocarb SCHEMBL29355904 0.82 KDM4E (1.00) LMNAPOLBKDM4EUSP2CSNK2A2
Chromocarb SCHEMBL432304 0.82 KDM4E (1.00) LMNAPOLBKDM4EUSP2CSNK2A2
SCHEMBL20886834 0.82 KMT2A (0.78) LMNAPOLBKDM4EALDH1A1TP53
SCHEMBL19476629 0.82 TP53 (1.00) LMNAUSP2ALDH1A1TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11485720-B2 Anti-infective agents UNIVERSITY OF DUNDEE (GB) 2022-11-01 US disclosed
EP-3472141-B1 ANTI-INFECTIVE AGENTS UNIV DUNDEE (GB) 2022-10-05 EP disclosed
US-20210101877-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2021-04-08 US disclosed
US-20210101877-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2021-04-08 US disclosed
US-20190225592-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2019-07-25 US disclosed
US-20190225592-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2019-07-25 US disclosed
EP-3472141-A1 ANTI-INFECTIVE AGENTS University Of Dundee (GB) 2019-04-24 EP disclosed
WO-2017221002-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2017-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11485720-B2 Anti-infective agents C1R, RRS1, ARG1 LMNA 2536/4885POLB 1211/4885KDM4E 2159/4885
US-20210101877-A1 ANTI-INFECTIVE AGENTS C1R, RRS1, ARG1 LMNA 2536/4885POLB 1211/4885KDM4E 2159/4885
US-20190225592-A1 ANTI-INFECTIVE AGENTS C1R, ARG1, MSR1 LMNA 2610/4885POLB 1062/4885KDM4E 2344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.